Last edition
News about Global Pharma
FX Shoulder Solutions Secures FDA Clearance for Full-Wedge Augmented Glenoid Baseplates
This clearance brings the total number of glenoid baseplate options to 18, providing a variety of solutions for surgeons addressing bone loss, defects, or complicated glenoid morphologies.
Global Pharma | 17/05/2024 | By Abha | 652
FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer
The approval is based on the encouraging response rate and duration of response (DoR) observed in clinical studies, under the FDA's accelerated approval pathway.
Global Pharma | 17/05/2024 | By Abha | 833
Granules India Records 2 Percent Growth in Revenue from Operations in Q4FY24
Granules India Ltd., has announced its financial results for the quarter and financial year ended March 31, 2024.
Global Pharma | 17/05/2024 | By Aishwarya | 1108
The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and supported over 68,000 OrthAlign cases.
Global Pharma | 16/05/2024 | By Manvi | 262
Avidity Biosciences Welcomes Simona Skerjanec to its Board of Directors
Avidity Biosciences, Inc. has strengthened its leadership with the appointment of Simona Skerjanec, M.Pharm, MBA to its board of directors.
Global Pharma | 16/05/2024 | By Aishwarya | 231
Cipla Extends its Investment in Achira to Advance in PoC Diagnostic
Cipla Ltd. has signed definitive agreements for further investment of up to INR 26 crore in Optionally Convertible Preference Shares of Achira Labs Pvt. Ltd., in four tranches, subject to completion of certain milestones.
Global Pharma | 16/05/2024 | By Aishwarya | 998
Atraverse Medical Receives FDA Clearance for HOTWIRE Radiofrequency Guidewire
This device enables zero exchange left-heart access while also serving as a rail for catheter-based therapy systems.
Global Pharma | 16/05/2024 | By Abha | 578
Teva Names Matthew Shields as New Executive Vice President
Teva Pharmaceutical Industries Ltd. has appointed Matthew Shields as Executive Vice President of Teva Global Operations (TGO) under manufacturing and supply division
Global Pharma | 16/05/2024 | By Aishwarya | 838
Lupin Secures ISO 14001 and ISO 45001 Certification for its Indian Sites and Centers
Lupin Ltd. has announced that all 12 of its manufacturing sites, its R&D Center, and its corporate office in India have completed rigorous audits and been certified by DNV for ISO 14001 — Environment Management Systems (EMS), and ISO 45001 — Occupational Health and Safety Management System (OHSMS).
Global Pharma | 16/05/2024 | By Aishwarya | 648
Activities are currently underway to finalize the seamless Phase 2/3 master protocol design that will evaluate multiple investigational therapies for the treatment of pancreatic cancer. An intent of the study is to produce registration-enabling data.
Global Pharma | 15/05/2024 | By Manvi | 434
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy